The North America botanical and plant derivative drug market is anticipated to expand at a CAGR of 2.40% over the forecast period of 2017-2025. The revenue generated by the market is predicted to rise from $5222 million in 2016 and reach $6600 million by the end of 2025. The United States and Canada are the countries analyzed for this region. The market is chiefly driven by government efforts to promote the FDA approved botanical drugs.
NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET FORECAST 2018-2026
North America Botanical and Plant Derivative Drug Market by Types (Terpenes, Steroids, Glycosides, Phenols & Other Types) by Therapeutic Applications (Oncology, Dermatology, Cns Disorders, Hormone Diseases, & Other) by Products & Geography
North America botanical and plant derivative drug market accounted for $3804 million in 2017. Over the forecast period of 2018-2026, the market is expected to rise with 7.57% CAGR and raise a net total of $7032 million.
To learn more about this report, request a free sample copy
The United States and Canada are the countries analyzed for this region. The market is chiefly driven by government efforts to promote the FDA approved botanical drugs. This is aided by various NIH (National Institutes of Health) Botanical Research Centers Program in the North American region. The market is segmented on the basis of types, products, and therapeutic applications. The FDA-approved New Drug Application (NDA) “Fulyzaq,” which is an indicator drug for HIV-related diarrhea is extracted from the blood-red latex of the croton trees in the region. These botanical drugs are cost-effective as compared to other conventional drugs available in the US market.
Bayer Healthcare Llc, Glenmark Pharmaceuticals Ltd, Analyticon Discovery Gmbh, GlaxoSmithKline, Piramal Phytocare Ltd, Abbott Laboratories, Tasly Pharmaceuticals Inc, Bionova, Eli Lilly And Company, Novartis International Ag, Medigene, Boehringer Ingelheim, Ranbaxy Laboratories Ltd (Acquired By Sun Pharmaceuticals Ltd) and others are few of the leading players in this botanical and plant derivative drug market.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- GLYCOSIDES IS QUICKLY RISING MARKET IN TERMS OF TYPES
- ONCOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF THERAPEUTIC APPLICATION
- HERBAL/TRADITIONAL TOPICAL ANALGESICS PRODUCT DEMAND IS GROWING RAPIDLY
- MARKET DYNAMICS
- DRIVERS
- GROWING APPLICATIONS IN DISEASES
- GROWING FDA APPROVALS
- TECHNOLOGICAL DEVELOPMENT IN THE MANUFACTURING PROCESS
- RISING DEMAND FOR TRADITIONAL MEDICINES
- GROWING FOCUS TOWARDS NATURAL SOURCE MEDICINES
- RESTRAINTS
- STRINGENT REGULATIONS REGARDING THE USE AND APPROVAL OF BOTANICAL DRUGS
- LIMITED ADOPTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
- OPPORTUNITIES
- RISING FDA APPROVALS FOR BOTANICAL DRUGS
- ESCALATING USAGE OF BOTANICAL DRUGS
- CHALLENGES
- PRESENCE OF SUBSTITUTES FOR BOTANICAL & PLANT DERIVATIVE DRUG
- TOXICITY RELATED ISSUES AND SAFETY CONCERNS
- DRIVERS
- MARKET SEGMENTATION
- MARKET BY TYPES 2018-2026
- TERPENES
- STEROIDS
- GLYCOSIDES
- PHENOLS
- OTHER TYPES
- MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
- ONCOLOGY
- DERMATOLOGY
- CNS DISORDERS
- HORMONE DISEASES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCTS 2018-2026
- HERBAL/TRADITIONAL TOPICAL ANALGESICS
- HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
- HERBAL/TRADITIONAL DIGESTIVE REMEDIES
- HERBAL/TRADITIONAL DERMATOLOGICAL
- HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL TONICS
- MARKET BY TYPES 2018-2026
- KEY ANALYTICS
- MANUFACTURING PROCESS
- VALUE CHAIN ANALYSIS
- LEGAL, POLICY AND REGULATORY FRAMEWORK
- PORTER’S FIVE FORCES ANALYSIS
- THREAT OF NEW ENTRANTS
- THREATS OF SUBSTITUTE PRODUCT
- BARGAINING POWER OF BUYER
- BARGAINING POWER OF SUPPLIER
- INTENSITY OF COMPETITIVE RIVALRY
- KEY BUYING CRITERIA
- GEOGRAPHIC ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIES
- MERGER & ACQUISITION
- PARTNERSHIP & COLLABORATION
- EXPANSION & INVESTMENT
- MARKET SHARE ANALYSIS
- KEY COMPANIES ANALYSIS
- KEY STRATEGIES
- COMPANY PROFILE
- ABBOTT LABORATORIES
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- ANALYTICON DISCOVERY GMBH
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- BAYER HEALTHCARE LLC
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- BOEHRINGER INGELHEIM
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- BIONOVA
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- BRISTOL-MYERS SQUIBB
- OVERVIEW
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- CURA PHARM
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- WILLMAR SCHWABE GMBH & CO. KG
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ELI LILLY AND COMPANY
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- GLAXOSMITHKLINE
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- GLENMARK PHARMACEUTICALS LTD.
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- INDENA VIALE ORTLES
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- LUPIN LTD
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- MEDIGENE
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- NOVARTIS INTERNATIONAL AG
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- SCOT ANALYSIS
- PFIZER
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- PIRAMAL PHYTOCARE LTD.
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- RANBAXY LABORATORIES LTD (ACQUIRED BY SUN PHARMACEUTICALS LTD)
- OVERVIEW
- PRODUCTION PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- SANOFI
- OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVE
- SCOT ANALYSIS
- TASLY PHARMACEUTICALS INC
- OVERVIEW
- PRODUCTION PORTFOLIO
- SCOT ANALYSIS
- ABBOTT LABORATORIES
TABLE LIST
TABLE 1 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET, 2018-2026 ($ MILLION)
TABLE 2 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET, BY TYPES 2018-2026 ($ MILLION)
TABLE 3 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES, 2018-2026 ($ MILLION)
TABLE 4 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)
TABLE 5 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES, BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 6 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS, 2018-2026 ($ MILLION)
TABLE 7 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)
TABLE 8 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET BY THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)
TABLE 9 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY, 2018-2026 ($ MILLION)
TABLE 10 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY, 2018-2026 ($ MILLION)
TABLE 11 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS, 2018-2026 ($ MILLION)
TABLE 12 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE, 2018-2026 ($ MILLION)
TABLE 13 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)
TABLE 14 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET, BY PRODUCT 2018-2026 ($ MILLION)
TABLE 15 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS, 2018-2026 ($ MILLION)
TABLE 16 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES, 2018-2026 ($ MILLION)
TABLE 17 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES, 2018-2026 ($ MILLION)
TABLE 18 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS, 2018-2026 ($ MILLION)
TABLE 19 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS, 2018-2026 ($ MILLION)
TABLE 20 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS, 2018-2026 ($ MILLION)
TABLE 21 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS, 2018-2026 ($ MILLION)
TABLE 22 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE LIST
FIGURE 1 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)
FIGURE 2 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN TERPENES 2018-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN STEROIDS 2018-2026 ($ MILLION)
FIGURE 4 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN GLYCOSIDES 2018-2026 ($ MILLION)
FIGURE 5 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN PHENOLS 2018-2026 ($ MILLION)
FIGURE 6 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHER TYPES 2018-2026 ($ MILLION)
FIGURE 7 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN ONCOLOGY 2018-2026 ($ MILLION)
FIGURE 8 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN DERMATOLOGY 2018-2026 ($ MILLION)
FIGURE 9 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN CNS DISORDERS 2018-2026 ($ MILLION)
FIGURE 10 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HORMONE DISEASE 2018-2026 ($ MILLION)
FIGURE 11 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN OTHERS THERAPEUTIC APPLICATIONS 2018-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TOPICAL ANALGESICS 2018-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES 2018-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIGESTIVE REMEDIES 2018-2026 ($ MILLION)
FIGURE 15 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DERMATOLOGICALS 2018-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL PAEDIATRIC DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)
FIGURE 17 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL DIETARY SUPPLEMENTS 2018-2026 ($ MILLION)
FIGURE 18 NORTH AMERICA BOTANICAL AND PLANT DERIVATIVE DRUG MARKET IN HERBAL/TRADITIONAL TONICS 2018-2026 ($ MILLION)
FIGURE 19 EVOLUTION OF BOTANICAL AND PLANT DERIVATIVE DRUGS
FIGURE 20 NORTH AMERICA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 21 UNITED STATES BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 22 CANADA BOTANICAL & PLANT DERIVATIVE DRUG MARKET 2018-2026 ($ MILLION)
FIGURE 23 BOTANICAL & PLANT DERIVATIVE DRUG MARKET SHARE 2017
- GEOGRAPHIC ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET SEGMENTATION
- MARKET BY TYPES 2018-2026
- TERPENES
- STEROIDS
- GLYCOSIDES
- PHENOLS
- OTHER TYPES
- MARKET BY THERAPEUTIC APPLICATIONS 2018-2026
- ONCOLOGY
- DERMATOLOGY
- CNS DISORDERS
- HORMONE DISEASES
- OTHER THERAPEUTIC APPLICATIONS
- MARKET BY PRODUCTS 2018-2026
- HERBAL/TRADITIONAL TOPICAL ANALGESICS
- HERBAL/TRADITIONAL COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
- HERBAL/TRADITIONAL DIGESTIVE REMEDIES
- HERBAL/TRADITIONAL DERMATOLOGICAL
- HERBAL/TRADITIONAL PEDIATRIC DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL DIETARY SUPPLEMENTS
- HERBAL/TRADITIONAL TONICS
- MARKET BY TYPES 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.